Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations(2 sites)
China
Peking University Third Hospital, Beijing, Beijing Municipality Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong